{"id":223811,"date":"2026-08-31T11:58:34","date_gmt":"2026-08-31T06:28:34","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=223811"},"modified":"2026-08-31T11:58:34","modified_gmt":"2026-08-31T06:28:34","slug":"why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/","title":{"rendered":"Glenmark Pharmaceuticals (GLENMARK) Share Price falls 2.01% as stock trades at Rs 2,466.90"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals (GLENMARK)<\/a> share price fell to Rs 2,466.9 today, down 2.01% from the previous close. Market cap was Rs 71,047.24 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;31 August 2026 at 11:49:45 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Glenmark Pharmaceuticals Share Price declined today as the stock closed at Rs 2,466.90, down 2.01% from the previous close, while the company\u2019s market capitalisation stood at Rs 71,047.24 crore. The session matters because the data confirms a same-day price fall without assigning a company-specific catalyst. For readers tracking Glenmark Pharmaceuticals on Univest, this is a clear price action event that can be read alongside the stock\u2019s valuation, sector context and published financial ratios. Glenmark Pharmaceuticals Share Price Today is therefore best understood through verified numbers rather than assumptions. The move also places Glenmark Pharmaceuticals Stock News in focus for market watchers looking at whether today\u2019s decline aligns with the broader pharmaceutical backdrop or stands out on its own.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Glenmark_Pharmaceuticals_GLENMARK_Share_Price_Today_Price_Action_Analysis\" title=\"Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis\">Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Glenmark_Pharmaceuticals_GLENMARK_Fundamental_Analysis\" title=\"Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis\">Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\" title=\"Why Investors Are Watching Glenmark Pharmaceuticals\">Why Investors Are Watching Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#About_Glenmark_Pharmaceuticals\" title=\"About Glenmark Pharmaceuticals\">About Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glenmark Pharmaceuticals Share Price on Univest\">Track Glenmark Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#Why_is_Glenmark_Pharmaceuticals_Share_Price_falling_today\" title=\"Why is Glenmark Pharmaceuticals Share Price falling today?\">Why is Glenmark Pharmaceuticals Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#What_is_Glenmark_Pharmaceuticals_Share_Price_today\" title=\"What is Glenmark Pharmaceuticals Share Price today?\">What is Glenmark Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#What_does_Glenmark_Pharmaceuticals_Share_Price_show_on_valuation\" title=\"What does Glenmark Pharmaceuticals Share Price show on valuation?\">What does Glenmark Pharmaceuticals Share Price show on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#How_does_Glenmark_Pharmaceuticals_compare_with_peers\" title=\"How does Glenmark Pharmaceuticals compare with peers?\">How does Glenmark Pharmaceuticals compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-08-31\/#What_should_investors_track_next_in_Glenmark_Pharmaceuticals_Stock_News\" title=\"What should investors track next in Glenmark Pharmaceuticals Stock News?\">What should investors track next in Glenmark Pharmaceuticals Stock News?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_GLENMARK_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,466.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,517.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 50.50 (-2.01%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,535<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,535<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,454.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.4 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 71,047.24 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price Today moved from a previous close of Rs 2,517.40 to Rs 2,466.90, a decline of Rs 50.50 or 2.01%. The stock opened at Rs 2,535.00, touched an intraday high of Rs 2,535.00 and a low of Rs 2,454.05. That sequence shows that the day began above the previous close, but the final price finished below it, leaving the session in negative territory.<\/p>\n<p>Turnover was Rs 3.4 crore, which is a factual traded-value figure for the session and should be read as part of the day\u2019s record rather than as an explanation for the fall. Glenmark Pharmaceuticals Share Price therefore reflects a measured decline in the day\u2019s session, with the low of Rs 2,454.05 marking the weakest point in today\u2019s price path. The stock is classified as a Large Cap company in the supplied data, and that market-cap category gives important size context for Glenmark Pharmaceuticals Stock News. In That makes the next step a careful look at valuation and sector positioning.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_GLENMARK_Fundamental_Analysis\"><\/span><strong>Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 71,047.24 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.48x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 388.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price should also be read against the company\u2019s core financial ratios. The stock\u2019s market capitalisation is Rs 71,047.24 crore, with an enterprise-value style context best understood through the supplied valuation metrics rather than inference. The P\/E ratio is 39.52 and the P\/B ratio is 6.48, both of which place Glenmark Pharmaceuticals among the more richly valued names in its industry set when compared with the supplied benchmark range. EPS is Rs 63.7, which shows the earnings attributable to each share, while book value is Rs 388.43, indicating the accounting net worth behind each share.<\/p>\n<p>ROE stands at 14.1% and ROCE at 20.35%, both useful as return measures when placed beside peers and sector medians. Dividend yield is 0.1%, a very small historical\/current payout measure relative to the share price. Glenmark Pharmaceuticals Share Price therefore combines a higher valuation profile with return ratios that can be compared against the pharmaceutical universe. For Glenmark Pharmaceuticals Stock Analysis, the main point is not a prediction but a factual one: today\u2019s price fall happened in a stock with established profitability metrics and a premium valuation versus several peers. That sets up the ownership and sector lens used by Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.7x to 672.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.48x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 71,047.24 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 670.73 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,040.53 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the Healthcare sector and the Pharmaceuticals &amp; Drugs industry, Glenmark Pharmaceuticals Share Price can be compared with a benchmark scope of 203 companies in the same industry. The company\u2019s P\/E of 39.52 is above the benchmark median of 31.21 and below the benchmark average of 48.1. Its P\/B of 6.48 is above the benchmark median of 2.88 and above the benchmark average of 4.19. ROE at 14.1% is above the benchmark median of 11.78% and above the benchmark average of 10.68%, while ROCE at 20.35% is above the benchmark median of 13.6% and above the benchmark average of 13.27%.<\/p>\n<p>The company\u2019s market capitalisation of Rs 71,047.24 crore is also well above the benchmark median market capitalisation of Rs 670.73 crore and below the benchmark average of Rs 14,040.53 crore when measured across the 203-company scope. This is useful context for Glenmark Pharmaceuticals Share Price Today because it shows how the stock sits within a broad pharmaceutical set that includes many companies with much smaller market values and mixed valuation profiles. In sector terms, Glenmark Pharmaceuticals Stock News today is not about a sector shock; it is about one large listed pharmaceutical company moving lower while still sitting within a valuation framework that is above the industry median on key multiples. Univest readers can use that contrast to understand the session in a wider market setting.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Among the supplied peers, Glenmark Pharmaceuticals Share Price sits below Sun Pharmaceutical Industries on market capitalisation but above Zydus Lifesciences, Cipla, Lupin, Aurobindo Pharma and Mankind Pharma on that measure. Its P\/E of 39.52 is above Zydus Lifesciences at 26.24, Cipla at 33.99, Lupin at 17.99 and Aurobindo Pharma at 25.57, while it is below Divi&#8217;s Laboratories at 84.12 and Torrent Pharmaceuticals at 87.81.<\/p>\n<p>On ROE, Glenmark Pharmaceuticals Share Price compares at 14.1%, ahead of Cipla at 11.83, Aurobindo Pharma at 9.93 and Dr. Reddy&#8217;s Laboratories at 11.69, but below Lupin at 27.11 and Torrent Pharmaceuticals at 26.76. On ROCE, the stock\u2019s 20.35% is above Sun Pharma at 19.11, Cipla at 16 and Dr. Reddy&#8217;s at 13.75, while below Lupin at 28.86 and Divi&#8217;s Laboratories at 21.51. For Glenmark Pharmaceuticals Stock Analysis, the peer set shows a company with mid-to-high valuation metrics and solid returns relative to several listed peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glenmark Pharmaceuticals Share Price fell 2.01% today to Rs 2,466.90, and the previous close was Rs 2,517.40.<\/li>\n<li>The day\u2019s range was Rs 2,454.05 to Rs 2,535.00, with the stock opening at Rs 2,535.00.<\/li>\n<li>Market capitalisation stood at Rs 71,047.24 crore, and Glenmark is classified as a Large Cap company in the supplied data.<\/li>\n<li>P\/E was 39.52, P\/B was 6.48, ROE was 14.1% and ROCE was 20.35%.<\/li>\n<li>In the same industry, Glenmark Pharmaceuticals Share Price is above the benchmark median on P\/E, P\/B, ROE and ROCE.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glenmark_Pharmaceuticals\"><\/span><strong>About Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company is part of a large listed pharmaceutical universe and is compared here against other quoted companies in the same industry set through Univest. Glenmark Pharmaceuticals Share Price Today can therefore be read alongside its market capitalisation of Rs 71,047.24 crore, valuation ratios and return metrics. Glenmark Pharmaceuticals Stock News in this article is strictly based on verified session data and financial ratios supplied in the dataset. For readers following Glenmark Pharmaceuticals Share News, the key is to track the company through its share price, valuation, and industry context rather than through assumptions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glenmark Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals (GLENMARK) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Univest lets users track Glenmark Pharmaceuticals Share Price, share price live, financial ratios, shareholding pattern, 52-week levels and market insights in one place. You can monitor Glenmark Pharmaceuticals Stock News, Glenmark Pharmaceuticals Latest News and Glenmark Pharmaceuticals Share Price Update through verified market data on Univest.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Glenmark_Pharmaceuticals_Share_Price_falling_today\"><\/span><strong>Why is Glenmark Pharmaceuticals Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals Share Price fell 2.01% to Rs 2,466.90 today, but the supplied data does not establish a company-specific catalyst. The session records the decline, open, high, low, turnover and market capitalisation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glenmark_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Glenmark Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals Share Price today is Rs 2,466.90. It was down Rs 50.50 from the previous close of Rs 2,517.40, and the company\u2019s market capitalisation stood at Rs 71,047.24 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Glenmark_Pharmaceuticals_Share_Price_show_on_valuation\"><\/span><strong>What does Glenmark Pharmaceuticals Share Price show on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals Share Price sits alongside a P\/E of 39.52 and a P\/B of 6.48. In the same industry benchmark, both multiples are above the median, giving important valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Pharmaceuticals_compare_with_peers\"><\/span><strong>How does Glenmark Pharmaceuticals compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals compares with Sun Pharma, Divi&#39;s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Cipla, Lupin, Dr. Reddy&#39;s, Aurobindo Pharma and Mankind Pharma on valuation and return ratios. Its P\/E and return metrics sit in the middle of the group.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_track_next_in_Glenmark_Pharmaceuticals_Stock_News\"><\/span><strong>What should investors track next in Glenmark Pharmaceuticals Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Investors can track the next session\u2019s price action, the company\u2019s financial ratios and the same-industry comparison on Univest. Glenmark Pharmaceuticals Share Price will also remain relevant relative to its market capitalisation and profitability metrics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals Share Price falls to Rs 2,466.9. marking a 2.01% fall today. Market cap stands at Rs 71,047.24 crore.<\/p>\n","protected":false},"author":29,"featured_media":223810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-223811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["223810"],"rank_math_title":["Glenmark Pharmaceuticals Share Price falls 2.01% today"],"rank_math_description":["Glenmark Pharmaceuticals Share Price fell 2.01% to Rs 2,466.90. Read price action, valuation, sector comparison and stock analysis today."],"rank_math_focus_keyword":["Glenmark Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Glenmark_Pharmaceuticals_GLENMARK_Share_Price_falls_201_as_stock_trades_at_Rs_246690_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=223811"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223811\/revisions"}],"predecessor-version":[{"id":223812,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223811\/revisions\/223812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/223810"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=223811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=223811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=223811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}